SHENKMAN CAPITAL MANAGEMENT INC - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 52 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
SHENKMAN CAPITAL MANAGEMENT INC ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q2 2020$499,000
+4.8%
451,000
-3.4%
0.07%0.0%
Q1 2020$476,000
+126.7%
467,000
+155.2%
0.07%
+163.0%
Q4 2019$210,000
-96.2%
183,000
-96.2%
0.03%
-95.7%
Q3 2019$5,514,000
-6.8%
4,780,000
-3.8%
0.63%
-6.0%
Q2 2019$5,919,000
-40.8%
4,971,000
-32.6%
0.67%
-47.8%
Q1 2019$9,994,000
+18.8%
7,379,000
-5.7%
1.28%
+4.5%
Q4 2018$8,411,000
+13.5%
7,823,000
+11.1%
1.23%
+37.0%
Q3 2018$7,410,000
-18.3%
7,040,000
-23.5%
0.90%
-18.0%
Q2 2018$9,066,000
+205.1%
9,204,000
+206.8%
1.10%
+244.3%
Q1 2018$2,971,0003,000,0000.32%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q4 2018
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 83,741,000$95,429,0006.49%
STEELHEAD PARTNERS LLC 52,496,000$59,911,0005.47%
SILVERBACK ASSET MANAGEMENT LLC 23,000,000$26,278,0004.02%
Castle Creek Arbitrage, LLC 10,734,000$12,253,0003.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 40,132,000$45,920,0002.81%
Sonora Investment Management, LLC 16,707,000$19,084,0001.99%
TFG Asset Management GP Ltd 8,500,000$9,718,0001.73%
Verition Fund Management LLC 27,901,000$31,890,0000.88%
SSI INVESTMENT MANAGEMENT LLC 7,872,000$8,977,0000.65%
SHENKMAN CAPITAL MANAGEMENT INC 4,780,000$5,514,0000.63%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders